Literature DB >> 26847210

Overexpression of SCARA5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the FAK signaling pathway.

Xinzhu Wen1, Nan Wang1, Fanfan Zhang2, Chunjiao Dong3.   

Abstract

Scavenger receptor class A, member 5 (SCARA5) is a member of the scavenger receptor family, and is involved in several types of human malignancy; however, its roles in osteosarcoma (OS) remain to be fully elucidated. Therefore, in the present study, the biological functions of SCARA5 in OS, and the potential underlying mechanisms were investigated. SCARA5 expression in OS tissues and cell lines was detected by reverse transcription‑quantitative polymerase chain reaction and western blot analysis. The effects of SCARA5 on the proliferation and migration/invasion ability of OS cells were determined by MTT and Transwell chamber assays, respectively. Expression levels of phosphorylated focal adhesion kinase (p‑FAK), FAK, p‑Src, Src, matrix metalloproteinase (MMP)2 and MMP9 were evaluated via western blot analysis. The results of the present study demonstrated that SCARA5 was expressed at low levels in OS tissues and cell lines. The overexpression of SCARA5 significantly inhibited the proliferation, colony formation and migration/invasion abilities of the OS cells. Furthermore, SCARA5 significantly decreased the expression levels of p‑FAK, MMP‑2 and MMP‑9 in the OS cells. Taken together, these data suggested that the overexpression of SCARA5 inhibits tumor proliferation and invasion in OS via suppression of the FAK signaling pathway. Thus, novel therapeutic strategies or drugs targeted at SCARA5 may offer potential for the treatment of OS.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26847210     DOI: 10.3892/mmr.2016.4857

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  11 in total

1.  CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.

Authors:  Hongliang Liu; Junwen Hu; Hua Pan; Dilai Luo; Mingwen Huang; Wei Xu
Journal:  Dig Dis Sci       Date:  2017-11-30       Impact factor: 3.199

2.  SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.

Authors:  Kai You; Fei Su; Lihua Liu; Xiaohong Lv; Jianguo Zhang; Yafang Zhang; Baoquan Liu
Journal:  Mol Cell Biochem       Date:  2017-05-11       Impact factor: 3.396

3.  Highly Expressing SCARA5 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma.

Authors:  Kawuli Jumai; Tangjuan Zhang; Bingzhang Qiao; Julaiti Ainiwaer; Haiping Zhang; Zhichao Hou; Idris Awut; Madinyat Niyaz; Liwei Zhang; Ilyar Sheyhidin
Journal:  J Immunol Res       Date:  2022-06-17       Impact factor: 4.493

4.  Carcinoma-associated fibroblasts release microRNA-331-3p containing extracellular vesicles to exacerbate the development of pancreatic cancer via the SCARA5-FAK axis.

Authors:  Yadong Han; Xu Qian; Teng Xu; Yang Shi
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

5.  SCARA5 plays a critical role in the commitment of mesenchymal stem cells to adipogenesis.

Authors:  Hyemin Lee; Yoo Jeong Lee; Hyeonjin Choi; Jo Woon Seok; Bo Kyung Yoon; Daeun Kim; Ji Yoon Han; Yoseob Lee; Hyo Jung Kim; Jae-Woo Kim
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

6.  Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.

Authors:  Chen Zheng; Er-Jie Xia; Rui-Da Quan; Adheesh Bhandari; Ou-Chen Wang; Ru-Tian Hao
Journal:  Cell Biochem Funct       Date:  2020-01-27       Impact factor: 3.685

7.  New Proteins Contributing to Immune Cell Infiltration and Pannus Formation of Synovial Membrane from Arthritis Diseases.

Authors:  Dominique de Seny; Dominique Baiwir; Elettra Bianchi; Gaël Cobraiville; Céline Deroyer; Christophe Poulet; Olivier Malaise; Geneviève Paulissen; Marie-Joëlle Kaiser; Jean-Philippe Hauzeur; Gabriel Mazzucchelli; Philippe Delvenne; Michel Malaise
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

8.  SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer.

Authors:  Jeeho Kim; Ho Jin You; Chakyung Youn
Journal:  BMC Cancer       Date:  2022-05-16       Impact factor: 4.430

9.  The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC.

Authors:  Qi Peng; Yan Liu; Xuehua Kong; Jie Xian; Lin Ye; Li Yang; Shuliang Guo; Yan Zhang; Lan Zhou; Tingxiu Xiang
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

10.  Fusion of Normoxic- and Hypoxic-Preconditioned Myoblasts Leads to Increased Hypertrophy.

Authors:  Tamara Pircher; Henning Wackerhage; Elif Akova; Wolfgang Böcker; Attila Aszodi; Maximilian M Saller
Journal:  Cells       Date:  2022-03-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.